Published in Virology on February 01, 1994
Replication of Epstein-Barr virus oriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays. J Virol (1995) 2.63
Human cytomegalovirus uracil DNA glycosylase is required for the normal temporal regulation of both DNA synthesis and viral replication. J Virol (1996) 1.90
The genome of Melanoplus sanguinipes entomopoxvirus. J Virol (1999) 1.84
Characterization of the single-stranded DNA binding protein encoded by the vaccinia virus I3 gene. J Virol (1998) 1.50
Repression of vaccinia virus Holliday junction resolvase inhibits processing of viral DNA into unit-length genomes. J Virol (2001) 1.39
Construction of a vaccinia virus deficient in the essential DNA repair enzyme uracil DNA glycosylase by a complementing cell line. J Virol (1997) 1.30
Requirement for uracil-DNA glycosylase during the transition to late-phase cytomegalovirus DNA replication. J Virol (2001) 1.28
Role of vaccinia virus A20R protein in DNA replication: construction and characterization of temperature-sensitive mutants. J Virol (2001) 1.26
Mutations in active-site residues of the uracil-DNA glycosylase encoded by vaccinia virus are incompatible with virus viability. J Virol (1996) 1.25
Poxvirus DNA primase. Proc Natl Acad Sci U S A (2007) 1.14
Identification and characterization of a double-stranded RNA- reovirus temperature-sensitive mutant defective in minor core protein mu2. J Virol (1996) 1.09
Human cytomegalovirus uracil DNA glycosylase associates with ppUL44 and accelerates the accumulation of viral DNA. Virol J (2005) 1.09
Poxvirus DNA replication. Cold Spring Harb Perspect Biol (2013) 1.02
Characterisation of the substrate specificity of homogeneous vaccinia virus uracil-DNA glycosylase. Nucleic Acids Res (2003) 1.01
Origin-independent plasmid replication occurs in vaccinia virus cytoplasmic factories and requires all five known poxvirus replication factors. Virol J (2005) 1.00
HIV DNA is heavily uracilated, which protects it from autointegration. Proc Natl Acad Sci U S A (2011) 1.00
Evaluation of the role of the vaccinia virus uracil DNA glycosylase and A20 proteins as intrinsic components of the DNA polymerase holoenzyme. J Biol Chem (2011) 0.99
Vaccinia virus D4 mutants defective in processive DNA synthesis retain binding to A20 and DNA. J Virol (2010) 0.98
Low-resolution structure of vaccinia virus DNA replication machinery. J Virol (2012) 0.92
Identification of polymerase and processivity inhibitors of vaccinia DNA synthesis using a stepwise screening approach. Antiviral Res (2008) 0.91
Orthopoxvirus targets for the development of antiviral therapies. Curr Drug Targets Infect Disord (2005) 0.90
Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies. PLoS One (2009) 0.90
Uracil within DNA: an actor of antiviral immunity. Retrovirology (2008) 0.89
Highly efficient induction of protective immunity by a vaccinia virus vector defective in late gene expression. J Virol (1999) 0.88
Crystal structure of the vaccinia virus DNA polymerase holoenzyme subunit D4 in complex with the A20 N-terminal domain. PLoS Pathog (2014) 0.85
Identification of inhibitors that block vaccinia virus infection by targeting the DNA synthesis processivity factor D4. J Med Chem (2011) 0.85
Crystal Structure of the Vaccinia Virus Uracil-DNA Glycosylase in Complex with DNA. J Biol Chem (2015) 0.81
Avian reovirus temperature-sensitive mutant tsA12 has a lesion in major core protein sigmaA and is defective in assembly. J Virol (2004) 0.78
A Conserved Tripeptide Sequence at the C-terminus of the Poxvirus DNA Processivity Factor D4 is Essential for Protein Integrity and Function. J Biol Chem (2016) 0.75
Sequence-nonspecific replication of transfected plasmid DNA in poxvirus-infected cells. Proc Natl Acad Sci U S A (1986) 1.71
Molecular epidemiology and genetic diversity of echovirus type 30 (E30): genotypes correlate with temporal dynamics of E30 isolation. J Clin Microbiol (1999) 1.62
Replication and resolution of cloned poxvirus telomeres in vivo generates linear minichromosomes with intact viral hairpin termini. J Virol (1986) 1.53
Tumorigenic poxviruses: genomic organization and DNA sequence of the telomeric region of the Shope fibroma virus genome. Virology (1987) 1.09
Efficient resolution of replicated poxvirus telomeres to native hairpin structures requires two inverted symmetrical copies of a core target DNA sequence. J Virol (1987) 1.03
Escape from mating-type incompatibility in bisexual (A + a) Neurospora heterokaryons. Can J Genet Cytol (1975) 1.00
A temperature-sensitive lesion in the small subunit of the vaccinia virus-encoded mRNA capping enzyme causes a defect in viral telomere resolution. J Virol (1991) 0.96
DNA ligase gene disruptions can depress viral growth and replication in poxvirus-infected cells. Virus Res (1998) 0.93
Cloning of the vaccinia virus telomere in a yeast plasmid vector. Gene (1984) 0.91
Identification of a temperature-sensitive mutant of vaccinia virus defective in late but not intermediate gene expression. Virology (1992) 0.90
Tumorigenic poxviruses: fine analysis of the recombination junctions in malignant rabbit fibroma virus, a recombinant between Shope fibroma virus and myxoma virus. Virology (1988) 0.89
Meiosis in Neurospora crassa. II. Genetic and cytological characterization of three meiotic mutants. Genetics (1980) 0.87
Interrupted aortic arch. A conservative approach for the sick neonate. J Thorac Cardiovasc Surg (1983) 0.87
Characterization of MMS-sensitive mutants of Neurospora crassa. Mutat Res (1982) 0.82
An etoposide-induced block in vaccinia virus telomere resolution is dependent on the virus-encoded DNA ligase. J Virol (1995) 0.79
Meiosis in Neurospora crassa. I. The isolation of recessive mutants defective in the production of viable ascospores. Genetics (1980) 0.78
Visual Observations of Nightglow from Manned Spacecraft. Science (1962) 0.75
New syndrome of spondylospinal thoracic dysostosis with multiple pterygia and arthrogryposis. Am J Med Genet (1997) 0.75